Unsolved questions and concerns about treatment of anti-neutrophil cytoplasm antibody-associated vasculitides

Chaigne, B.; Guillevin, Lïc.

Clinical and Experimental Rheumatology 34(3 Suppl. 97): S121-S128

2016


ISSN/ISBN: 0392-856X
PMID: 27087528
Document Number: 687785
The treatment strategy for vasculitis has changed dramatically over the last few years, but some major questions remain. Herein, after reviewing the literature, we provide answers to, or at least an analysis of, available evidence on 10 specific and practical questions concerning ANCA-associated vasculitis management.

Document emailed within 1 workday
Secure & encrypted payments